Skip to content

Effect of Implant Treatment and/or Dietary Advice on the Nutrition of Edentulous Ageing Subjects

Does the Rehabilitation of Masticatory Function and/or Brief Dietary Advice Improve the Diet and Nutrition of Older Subjects With Terminal Dentition or Full Edentulism? A Factorial Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05334407
Enrollment
120
Registered
2022-04-19
Start date
2022-04-18
Completion date
2024-12-31
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulous Jaw, Periodontitis

Keywords

nutrition, implant-supported fixed prosthesis, diet intake, healthy ageing, masticatory function

Brief summary

Loss of masticatory function consequent to tooth loss is associated with changes in food choices and insufficient nutrition intake. To date, studies showed no significant improvement in nutrient intake with interventions based solely on dental prostheses. Pilot studies have shown positive impacts of interventions combining implant-supported fixed dental prosthesis with brief dietary interventions. The relative contribution and the potential synergy of the components of such interventions need to be determined as it has major public health implications for the community-dwelling ageing population that continues to disproportionately suffer from tooth loss and its consequences. This study tests the effect of rehabilitation of masticatory function with fixed implant supported dentures and diet re-education on the dietary intake and nutrition in older subjects with terminal dentition (stage IV periodontitis) or full edentulism. A 2 × 2 factorial randomized controlled trial of eligible adult (≥60 years) with loss of masticatory function consequent to full arch edentulism or terminal dentition (n = 120) will be conducted to test whether the rehabilitation of masticatory function with fixed implant supported dentures, diet re-education and/or their combination improves the diet and nutrition of ageing subjects. The study has been designed to detect changes in fruit and vegetable intake at 4 months using the 24-hour dietary recall method. Changes in protein as percentage of total energy, nutritional biomarkers, metabolomics, oral and gut microbiome, quality of life and masticatory function will also be assessed.

Detailed description

Complete edentulism or presence of a terminal dentition that is functionally compromised in an irreparable way represent the end of the spectrum of caries and periodontitis, eventually leading to loss of masticatory function. These subjects tend to show change in their diet behavior choosing softer diets with higher carbohydrates and fat and less fresh fruit and vegetables. Accumulating evidence points to the presence of an association between changes in dietary behavior consequent to tooth loss and insufficient nutrition intake. Such impaired nutrition may have long term effects on muscle strength and physical decline, and be detrimental to general health. Indeed, the recent GBD study of dietary risk factors identifies 15 important disease associated exposures. Their analysis shows that 5 of the health associated exposures: consumption of fruit, vegetables, whole grains, nuts, and fiber require a good level of mastication. While the physiology of mastication is an essential component of alimentation and contributes to the broader process of nutrition, a more holistic approach is needed to properly establish the scientific basis of the contribution of oral health to nutrition and healthy ageing. Assuming a potential cause-effect relationship between the inadequate food choice consequent to tooth loss and compromised nutrition intake, several studies have tried to improve the nutrient intake among edentulous individuals with various types of dentures. However, this goal has not been readily achieved with either complete denture or implant-retained overdenture, given the function limitation on these prosthesis and the lack of dietary intervention. A small-scale case series has shown that implant-supported fixed prosthesis resulted in more efficient mastication and improved nutrient intake compared with conventional and implant-based removable dentures in partial edentulism. However, no evidence is available regarding the effect of re-establishment of masticatory function with an implant-supported fixed prosthesis in edentulous patients. Moreover, with the increasing evidence suggesting a positive impact of nutrition counselling on the dietary intake, brief dietary advice has been advocated to help patients make full use of the enhanced masticatory function to improve their diet. Ellis et al. further showed that the impact of dietary advice on patient's satisfaction with dentures and oral health-related quality of life depends on the nature of the prosthesis. No trial has been performed to assess the benefit of dietary advice only or the combined effect of re-establishment of masticatory function with an implant-supported fixed prosthesis and dietary advice in edentulous elderly subjects. This is a 2 × 2 factorial clinical trial aimed to assess the effect of rehabilitation of masticatory function with fixed implant supported dentures and simultaneous diet re-education on the diet intake and nutrition in ageing subjects with terminal dentition (stage IV periodontitis) or full edentulism.

Interventions

PROCEDUREImplant-supported full-arch fixed dental prostheses(dental intervention,DE)

Implant-supported full-arch fixed dental prostheses in at least one jaw and appropriate treatment in the opposing jaw regarding periodontal diseases, caries, replacement of missing teeth and soft tissue disorders to get at least 10 pairs of occluding teeth. The intervention is designed to provide rehabilitation of masticatory function.

BEHAVIORALDietary intervention tailored to the dental status (dietary intervention, DI)

Dietary intervention based on the health Belief Model (HBM) with the behavioral goal of increasing an individual's likelihood of food intake regarding fresh vegetables, fresh fruits, and high quality protein for the potential intervention strategies. Participants will receive 20 minutes' coordinated dietary advice in the form of the slideshow presentation . A pamphlet prepared with reference to the Supplementary Guidelines for Elderly Populations, the 4th edition of the Dietary Guidelines for Chinese will be given to the participant separately. If a participant does not prepare his or her own meals, the person who does the cooking receives the dietary advice as well.

PROCEDUREDelayed implant-supported full-arch fixed dental prostheses(dental intervention,DE)

Delayed (4 months) implant-supported full-arch fixed dental prostheses in at least one jaw and appropriate treatment in the opposing jaw regarding periodontal diseases, caries, replacement of missing teeth and soft tissue disorders to get at least 10 pairs of occluding teeth. The intervention is designed to provide rehabilitation of masticatory function.

BEHAVIORALDelayed dietary intervention tailored to the dental status (dietary intervention, DI)

Dietary intervention based on the health Belief Model (HBM) with the behavioral goal of increasing an individual's likelihood of food intake regarding fresh vegetables, fresh fruits, and high quality protein for the potential intervention strategies. Participants will receive 20 minutes' coordinated dietary advice in the form of the slideshow presentation . A pamphlet prepared with reference to the Supplementary Guidelines for Elderly Populations, the 4th edition of the Dietary Guidelines for Chinese will be given to the participant separately. If a participant does not prepare his or her own meals, the person who does the cooking receives the dietary advice as well.

Sponsors

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Masking description

Timing of treatment will be concealed to the therapist and to the examiners. All laboratory assessments will be performed blindly.

Intervention model description

2x2 factorial design (4 month follow up) and longitudinal follow-up to 12 months

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* being edentulous or having the presence of terminal dentition (defined as few remaining teeth insufficient in terms of number, position and health status to provide adequate anchorage to a tooth supported or a tooth retained denture) and looking for implant-supported fixed denture treatment * accepted treatment plan for fixed implant-supported prosthesis restoring at least 10 pairs of occluding teeth * self-reported inadequate vegetable or fruit or protein intakes (patients were included if at least one of the three criteria listed below were met) I. Patients with a total average daily intake of \< 80 g of poultry, meat and aquatic product. II. Patients with an average daily intake of \< 200 g of fruit. III. Patients with an average daily intake of \< 300 g of vegetables. * understand written and spoken Chinese and who could respond to Chinese questionnaires * able and willing to give informed consent for participation in the study * able and willing to comply with 12-month follow-up

Exclusion criteria

* general contraindications to elective oral surgery procedures * local contraindications to implant-supported immediate-loading fixed prosthesis (e.g. limited jaw opening, insufficient bone volumes/densities) * looking for replacement of existing implant-retained overdenture with implant-supported fixed denture treatment * presence of infectious disease, acute or chronic symptoms of TMJ disorder * psychiatric disorder, dementia * any dietary restriction, currently taking nutrient supplements or inability to choose his/her diet. * uncontrolled diabetes (HbA1c≥7.0%) * self-reported heavy smokers (\>10 cigarette/day)

Design outcomes

Primary

MeasureTime frameDescription
changes in intake of fruit and vegetablesfrom baseline to 4-monthThree 24-hour dietary recall will be conducted through interview, twice on weekdays and once on weekend. The data on food consumption will be converted into the corresponding nutrient contents based on the China Food Composition Tables Standard Edition

Secondary

MeasureTime frameDescription
Masticatory functionat baseline, 4, 8, 12 and 16 monthsAbility to mix a two-color chewing gum with 20 masticatory cycles. The obtained bolus will be pressed to a standardized height and a color image will be acquired. Quantitative data will be obtained by digital analysis of the image using variance of hue as the outcome
Peri-implant oral hygieneat 4, 8, 12 and 16 months for groups with implantsModified plaque index (mPI) measured by periodontal probing
Peri-implant soft and hard tissue health (probing depth)at 4, 8, 12 and 16 months for groups with implantsPeri-implant probing depth (PD) measured by periodontal probing
Peri-implant soft and hard tissue health (local inflammation)at 4, 8, 12 and 16 months for groups with implantsPeri-implant modified bleeding index (mBI) measured by periodontal probing
Peri-implant radiographic bone level stability4, and 12 months after dental implant placement (in the context of standard care)Standardized panoramic radiographic imaging will be conducted to assess the peri-implant bone level.
OHIP-14 questionnaireat baseline, 4, 8, 12 and 16 monthsthe impact of oral health on the quality of life of participants assessed with the oral health impact profile (OHIP)-14. A 5-point scale was used to calculate the score for each of 14 items. The total score of OHIP-14 is in the range of 0 to 56 with higher values indicating more frequent impacts
Metabolism and systemic inflammatory biomarkers (i)at baseline, 4, 8, 12 and 16 monthsblood plasma concentration of homocysteine (gas chromatography)
Metabolism and systemic inflammatory biomarkers (ii)at baseline, 4, 8, 12 and 16 monthsPlasma hs-CRP assessed by immunoturbidometry
Metabolism and systemic inflammatory biomarkers (iii)at baseline, 4, 8, 12 and 16 monthsPlasma TNF-α (ELISA)
Metabolism and systemic inflammatory biomarkers (iv)at baseline, 4, 8, 12 and 16 monthsPlasma IL-1β (ELISA)
Metabolism and systemic inflammatory biomarkers (v)at baseline, 4, 8, 12 and 16 monthsPlasma IL-6 (ELISA)
Oxidative stress biomarkers (i)at baseline, 4, 8, 12 and 16 monthsPlasma Co Q10 with liquid chromatography-mass spectrometry
Oxidative stress biomarkers (ii)at baseline, 4, 8, 12 and 16 monthsPlasma uric acid (the enzymatic method)
Oxidative stress biomarkers (iii)at baseline, 4, 8, 12 and 16 monthsPlasma superoxide dismutase (the chemical colorimetric method)
Nutritional biomarker(Plasma vitamin A)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma vitamin A assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(Plasma vitamin B2)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma vitamin B2 assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(Plasma vitamin B12)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma vitamin B12 assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(Plasma folate)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma folate assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(plasma β-carotene)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma α-carotene assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(Plasma vitamin C)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma vitamin C assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(Plasma vitamin E)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma vitamin E assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(plasma α-carotene)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma α-carotene assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(plasma β-cryptoxanthin)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma β-cryptoxanthin assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(plasma lycopene)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma lycopene assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(plasma lutein/zeaxanthin)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma lutein/zeaxanthin assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(plasma α-tocopherols)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma α-tocopherols assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(plasma γ-tocopherols)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma γ-tocopherols assessed by liquid chromatography-mass spectrometry
Nutritional biomarker(Plasma total cholesterol)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma total cholesterol (Enzymatic Measurements)
Nutritional biomarker(Plasma HDL cholesterol)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma HDL cholesterol (Enzymatic Measurements)
Nutritional biomarker(Plasma LDL cholesterol)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma LDL cholesterol (Enzymatic Measurements)
Nutritional biomarker(Plasma triglycerides)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma triglycerides (Enzymatic Measurements)
Nutritional biomarker(Plasma Lpa)at baseline, 4, 8, 12 and 16 monthsconcentration of plasma Lpa (Enzymatic Measurements)
Metabolomics (Metabolites)at baseline, 4, 8, 12 and 16 monthsProfiling of annotated plasma metabolites (Differential plasma metabolites with P-value\< 0.05 and fold change≥2 or FC≤0.5) based on untargeted metabolomics using liquid chromatography coupled with mass spectrometry analyses
Metabolomics (Oxylipidomics)at baseline, 4, 8, 12 and 16 monthsProfiling of annotated plasma lipid metabolites (Differential lipid metabolites with P-value\< 0.05 and fold change≥2 or FC≤0.5) based on untargeted metabolomics using liquid chromatography coupled with mass spectrometry analyses
Microbiome Analysis(saliva)at baseline, 4, 8, 12 and 16 monthsTaxonomic profiling with 16S rRNA gene sequencing in saliva samples
Microbiome Analysis(plaque)at baseline, 4, 8, 12 and 16 monthsTaxonomic profiling with 16S rRNA gene sequencing in subgingival plaque samples
Microbiome Analysis(stool)at baseline, 4, 8, 12 and 16 monthsTaxonomic profiling with 16S rRNA gene sequencing in stool samples
Nutrient intakeat baseline, 4, 8, 12 and 16 monthsThe intake of fruit and vegetables, protein% of total energy according to a modified version of food-frequency questionnaire
Muscle strengthat baseline, 4, 8, 12 and 16 monthsmuscle strength assessed by Hand grip dynamometer
Cognitive function(i)at baseline, 4, 8, 12 and 16 monthscognitive function assessed with the Mini-Mental State Examination with a total score of 30. Score 27-30: normal cognition;Score 21-26: mild cognitive impairment;Score 10-20: moderate cognitive impairment;Score \<10: severe cognitive impairment
Cognitive function(ii)at baseline, 4, 8, 12 and 16 monthsdementia screening with the Alzheimer's disease eight-item tool. With Score 0: no cognitive impairment, Score 1-2: cognitive impairment; Score\>=3: dementia
Depression symptomsat baseline, 4, 8, 12 and 16 monthsassessment with the shortened Center for Epidemiologic Studies Depression Scale. The total score is the sum of 10 items. A score equal to or above 10 is considered depressed.
Nutritional statusat baseline, 4, 8, 12 and 16 monthsassessment by Mini-nutrient status form with a score of 12-14 corresponding to normal nutritional status;8-11 at risk of malnutrition;0-7 malnourished

Countries

China

Contacts

Primary ContactShujiao Qian, PhD
qianshujiao@gmail.com15121036374
Backup ContactMaurizio Tonetti, DMD,PhD
maurizio.tonetti@ergoperio.eu15000102368

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026